cor2ed
engage checkpoint medical linkedin twitter
bg

NTRK gene fusions, TRK inhibitors and testing approaches BluePrint

NTRK gene fusions, TRK inhibitors and testing approaches BluePrint

Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Assoc. Prof. Gerald Prager

NTRK CONNECT identified NTRK Gene Fusions on the ESMO OncologyPro portal as a practical guide on how to test for NTRK gene fusions and treat with TRK inhibitors.
Prof. Andrea Sartore-Bianchi

Medical Oncologist

Niguarda Cancer Center

Italy

Prof. Fernando López-Ríos

Pathologist

12 de Octubre University Hospital, Madrid

Spain

Assoc. Prof. Gerald Prager

Medical Oncologist

Medical University of Vienna

Austria

preview next

time | open 5 min | 2019

download resources

This programme was made for you:   your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

NTRK CONNECT have now developed BluePrint documents as a reference guide providing a concise overview in downloadable formats. A variety of topics are covered including, overview of gene fusions and role as oncogenic drivers, detection approaches available, NTRK family and NTRK gene fusions, epidemiology of cancers with NTRK gene fusions and an overview of TRK inhibitors.

Prof. Andrea Sartore-Bianchi (NTRK CONNECT), Dr. Jaclyn Hechtman, Prof. Fernando Lopez-Rios (NTRK CONNECT), Assoc. Prof. Gerald Prager have developed this resource with COR2ED.

PRECISION ONCOLOGY CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca and Bayer.

Other programmes of interest

Other programmes developed by Prof. Andrea Sartore-Bianchi

Prof. Andrea Sartore-Bianchi

Medical Oncologist

Niguarda Cancer Center

Italy

preview next

Other programmes developed by Prof. Fernando López-Ríos

Other programmes developed by Assoc. Prof. Gerald Prager

Assoc. Prof. Gerald Prager

Medical Oncologist

Medical University of Vienna

Austria

preview next